The Lancet Newsdesk - Tuberculosis vaccine for HIV-infected patients shows promise
A new tuberculosis vaccine reduces the incidence of the disease by 37% in HIV-positive people, according to phase lll study data presented at the 39th Union World Conference on Lung Health, Paris, France (Oct 16-20,2008). Full story here.
Other Fogarty Projects
News & Updates
- Fogarty East Africa Tuberculosis Consortium Holds Third Annual Meeting in Tanzania
- First Dartmouth College Fogarty Alumni Meeting
- The Lancet Newsdesk - Tuberculosis vaccine for HIV-infected patients shows promise
- Dartmouth-led Research Team Awarded 5 Year, $1.5 Million Grant to FIght Spread of HIV/AIDS and TB in Africa
- Dartmouth Medical School receives $1.6 million in AIDS funding